Condition
Skeletal Abnormalities
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Withdrawn2
Terminated1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT02298699Withdrawn
Biomarker for Sly Disease (MPS VII) (BioSly)
NCT02298673WithdrawnPrimary
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)
NCT03651245Terminated
European Alpha-Mannosidosis Participant
NCT03983265Not ApplicableUnknownPrimary
Condylar Segment Repositioning Using CAD/CAM Generated Wafer After BSSO in Skeletal Mandibular Deformity
Showing all 4 trials